期刊文献+

人甲状旁腺素N端34肽基因的合成、克隆及融合表达 被引量:3

Synthesis Cloning and Fusion Expression of the Human Parathyroid Hormone N terminus 34 Peptide Gene
下载PDF
导出
摘要 选用大肠杆菌偏爱的密码子,用计算机辅助设计、合成长度分别为59 、59 及60 碱基的三段寡核苷酸。以中段寡核苷酸为模板,两端寡核苷酸为引物,经PCR 合成完整的hPTH(134) 基因,并克隆到pUC18 载体中。对克隆基因进行序列分析,结果与设计的完全一致。将该基因与表达载体pKA 连接构建表达质粒pKAT,转化大肠杆菌JM105 细胞,SDSPAGE 表明hPTH(134) 融合蛋白获得了表达,并且酸水解后融合蛋白被裂解为大小两个片段。 The human parathyroid hormone (PTH) N terminal 34 peptide gene has been synthesized and cloned. Computer progamming was applied to the design of optimized segments for the synthesis of the hPTH(1 34) gene using preferred codons for expression in E.coli .Three segments with 59,59 and 60 base long were synthesized while W1 was homologous with W2 and W2 complementary to W3.The entire gene of 140bp was obtained by PCR and cloned into pUC18.Recombiant plasmid was transformed into host E.coli JM105 and positive clonies were screened. The DNA sequence of the cloned hPTH(1 34) gene was proved to be identical with designed DNA sequence . The hPTH(1 34) gene was inserted into expression vector pKA which contains L AnsB gene .The recombiant plasmid pKAT was used to transform E.coli JM105. After IPTG induced 2h, SDS PAGE proved that fusion protein was expressed in JM105. Then, fusion protein was cleaved by acid successfully.
出处 《中国药科大学学报》 CAS CSCD 北大核心 1999年第3期216-219,共4页 Journal of China Pharmaceutical University
基金 国家自然科学基金!编号:39870175 江苏省自然科学基金资助项目!编号:BK95092309 。
关键词 人甲状旁腺素(134) 聚合酶链式反应 基因克隆 融合表达 Human parathyroid hormone (1 34) Polymerase chain reaction Gene cloning Fusion expression
  • 引文网络
  • 相关文献

参考文献3

二级参考文献2

  • 1Tang J G,Biotechnol Lett,1993年,15卷,661页
  • 2Huang M,Life Sci,1983年,32卷,1009页

共引文献24

同被引文献43

  • 1Fjita T, Inoue T, Morii H. Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: A randomized double-masked prospective study using three dose level. Osteopos Int, 1999,9:296 - 306.
  • 2Whiefield J F, Morley P. Small bone-building fragments of PTH: new therapeutic agent for osteoporosis. Trends Pharmacol Sci, 1995,16( 11 ) :382 - 386.
  • 3Suzuki Y, Yabuta M, Ohsuye K. High-level production of recombinant human parathyroid hormone 1-34. Appl Environ Microbiol, 1998,64(2) :526 - 529.
  • 4Hendy G N, Kronenberg H M, Potts J T. Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone, Proc Natl Acad Sci USA, 1981,78:7365 - 7369.
  • 5Sambrook J, Fritsch E F, Maniats T. Molecular Cloning: A Laboratory Manual, 2nd ed. New York : Cold Spring Harbor Laboratory Press, 1989.
  • 6Bronstein P, Balian G. Cleavage at Asn-Gly bonds with hydroxylamine.Methods Emymol, 1977,47 : 132 - 145.
  • 7Frost A, Jonsson K B, Brandstrom H. Intereukin(IL)-13 and IL-14 inhibit proliferation in human osteoblast: evidence for involvment of receptor subunits IL-13Ra and IL-4a. J Bone ,2001,28(3) :268 - 274.
  • 8Ganta D R, McCarthy M B, Gronowicz G A. Ascorbic acid alters collagen integrins in bone culture. Endocrinology, 1997,138(9) :3606 - 3612.
  • 9Joha A P, Steven A H, Riggs B L. Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology, 1997,138 : 2919 - 2924.
  • 10Olstad O K, Jemtland R, Loseth O P, et al. Expression and characterization of a recombinant human parathyroid hormone partial agonist with antagonistic properties: Gly-hPTH( - 1→ + 84). Peptides,1995,16(6) : 1031 - 1037.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部